CVS HEALTH Corp
About CVS HEALTH Corp
CVS Health offers a diverse set of healthcare services. Its roots are in its retail pharmacy operations, where it operates around 9,000 stores primarily in the US. CVS is also a large pharmacy benefit manager (acquired through Caremark), processing about 2 billion adjusted claims annually. It operates a top-tier health insurer (acquired through Aetna) through which it serves about 27 million medical members. The acquisition of Oak Street Health added primary care services to the mix, which could have significant synergies with all existing business lines.
This profile is unclaimed. An authorized representative can claim it to add details and earn the Verified badge.
Financial summary
- Revenue FY2025
- $402.1B
- Net income
- $1.8B
- Total assets
- $253.5B
- Market cap
- $122.4B
- Gross margin
- 39.3%
- Operating margin
- 3.8%
- Net margin
- 2.3%
Source: SEC EDGAR · updated Jun 7, 2026
Revenue & profit trend
Financial statements
Income statement
- Revenue
- $357.8B
- Cost of revenue
- $217.1B
- Gross profit
- $140.7B
- Operating expenses
- $126.9B
- Operating income
- $13.7B
- Income tax
- $2.8B
- Net income
- $8.4B
- EPS (basic)
- $6.49
- EPS (diluted)
- $6.47
Balance sheet
- Total assets
- $249.7B
- Current assets
- $67.9B
- Total liabilities
- $173.1B
- Current liabilities
- $79.2B
- Shareholders’ equity
- $76.6B
Cash flow
- Operating cash flow
- $13.4B
- Investing cash flow
- -$20.9B
- Financing cash flow
- $2.7B
- Net cash flow
- -$4.8B
Statements via Polygon.io (SEC filings)
15-minute delayed · data by Polygon.io
Past year
52-week range
- Market cap
- $122.4B
- P/E ratio
- 15.0
- EPS (diluted)
- $6.47
- Dividend yield
- 2.74%
- Shares outstanding
- 1.3B
- Open
- —
- Day range
- –
- Prev close
- —
- Volume
- —
- IPO date
- Oct 1, 1952
Market data by Polygon.io · prices are 15-minute delayed
At a glance
- Profitable — net income of $1.8B in FY2025.
- Revenue grew 39% from FY2019 to FY2023.
- Gross margin of 39.3%, net margin 2.3%.
- Trading near its 52-week high.
- Pays a dividend yielding about 2.74% annually.
- Valued at a price-to-earnings (P/E) ratio of 15.0.
Automatically generated from public filings and market data. Informational only — not investment advice or a recommendation to buy or sell any security.
Peers & competitors
No reviews yet. Be the first to review CVS HEALTH Corp.
Write a review
News about CVS HEALTH Corp
News & sentiment via Polygon.io
